サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1339320

遺伝学的検査市場、シェア、規模、動向、産業分析レポート：疾患タイプ別、技術別、地域別、セグメント別予測、2023年～2032年

Hereditary Testing Market Share, Size, Trends, Industry Analysis Report, By Disease Type (Hereditary Cancer Testing and Hereditary Non-Cancer Testing); By Technology; By Region; Segment Forecast, 2023 - 2032
出版日: | 発行: Polaris Market Research | ページ情報: 英文 118 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
遺伝学的検査市場、シェア、規模、動向、産業分析レポート：疾患タイプ別、技術別、地域別、セグメント別予測、2023年～2032年
出版日: 2023年07月23日
発行: Polaris Market Research
ページ情報: 英文 118 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、世界の遺伝学的検査市場規模は2032年までに130億3,000万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

遺伝学的検査市場は、様々な要因により大きな成長を遂げています。遺伝性疾患の有病率の増加、疾患の早期発見の重要性に対する意識の高まり、遺伝子検査技術の進歩などがこの市場の拡大に寄与しています。遺伝学的検査は、遺伝子変異や異常を特定する上で極めて重要であり、早期介入、個別化治療、患者とその家族に対する十分な情報に基づいた意思決定を可能にします。

さらに、遺伝学的検査市場では、女性のヘルスケアと生殖遺伝学的健康に注目する動きが顕著です。企業は、妊娠中の遺伝性疾患のリスクを評価し、十分な情報に基づいた選択を可能にするため、キャリアスクリーニングや出生前検査など、女性の健康に特化した検査を開発・提供しています。

しかし、COVID-19の大流行は遺伝学的検査市場に課題をもたらしました。対面診察や検査室業務の制限を含むヘルスケア・サービスの混乱は、市場の成長に影響を与えました。それにもかかわらず、市場は遠隔医療を採用することで回復力を示し、遺伝学的検査サービスの需要を維持する上で出生前検査の重要性を認識しています。遺伝学への理解が進み、技術が進化し続けるにつれて、遺伝学的検査市場は今後さらに拡大すると予想されます。

遺伝学的検査市場レポートハイライト

遺伝性非がん検査分野が2022年の市場を独占し、大幅な成長が予測されます。主要企業は収益創出のために乳がん遺伝学的検査を戦略的にターゲットとしています。

分子検査セグメントは2022年に市場リーダーに浮上し、市場参入企業による採用の増加と戦略的イニシアティブにより、力強い成長を維持すると予測されます。

欧州は、大手遺伝子検査企業、先進治療の普及、遺伝学的検査を推進する政府規制により、2022年に最大の収益市場シェアを占め、優位性を維持すると予測されます。

世界の主要市場プレイヤーは、AL-KO KOBER GROUP、Andreas Stihl AG &Company KG、Ariens Company、Briggs &Stratton、CHEVRON（China）Trading Co., Ltd.、Deere &Company、Emak S.p.A.、Excel Industries, Inc.、HONDA、Husqvarna、Makita Corp.、MTD Holdings Inc.、Robert Bosch、Schiller Ground Care、Stanley Black &Decker、STIHL Group、Techtronic Industries、The Toro Company（米国）、Yamabiko Corp.

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界の遺伝学的検査市場に関する洞察

  • 遺伝学的検査市場- 業界スナップショット
  • 遺伝学的検査市場力学
    • 促進要因と機会
      • 遺伝性疾患の頻度の増加、悪影響に対する国民の意識の高まり、遺伝子解析の進歩がこの市場の主な推進力
      • 成長する生殖遺伝的健康分野
    • 抑制要因と課題
      • 高額な遺伝学的検査費用
  • PESTLE分析
  • 遺伝学的検査業界の動向
  • バリューチェーン分析
  • COVID-19感染症の影響分析

第5章 世界の遺伝学的検査市場、疾患タイプ別

  • 主な調査結果
  • イントロダクション
  • 遺伝性がん検査
  • 肺がん
  • 乳がん
  • 結腸直腸がん
  • 子宮頸がん
  • 卵巣がん
  • 前立腺がん
  • 胃・胃がん
  • 黒色腫
  • 肉腫
  • 子宮がん
  • 膵臓がん
  • その他
  • 遺伝性非がん検査
  • 遺伝子検査
  • 心臓病
  • 希少疾患
  • その他の病気
  • 新生児遺伝子スクリーニング
  • 着床前遺伝子診断とスクリーニング
  • 非侵襲的出生前検査（NIPT）および保因者スクリーニング検査

第6章 世界の遺伝学的検査市場、技術別

  • 主な調査結果
  • イントロダクション
  • 細胞遺伝学
  • 生化学
  • 分子検査

第7章 世界の遺伝学的検査市場、地域別

  • 主な調査結果
  • イントロダクション
    • 遺伝学的検査市場評価、地域別、2019～2032年
  • 遺伝学的検査市場-北米
    • 北米：遺伝学的検査市場、技術別、2019～2032年
    • 北米：遺伝学的検査市場、疾患タイプ別、2019～2032年
    • 遺伝学的検査市場-米国
    • 遺伝学的検査市場- カナダ
  • 遺伝学的検査市場- 欧州
    • 欧州：遺伝学的検査市場、技術別、2019～2032年
    • 欧州：遺伝学的検査市場、疾患タイプ別、2019～2032年
    • 遺伝学的検査市場- 英国
    • 遺伝学的検査市場- フランス
    • 遺伝学的検査市場- ドイツ
    • 遺伝学的検査市場- イタリア
    • 遺伝学的検査市場- スペイン
    • 遺伝学的検査市場- オランダ
    • 遺伝学的検査市場- ロシア
  • 遺伝学的検査市場- アジア太平洋
    • アジア太平洋：遺伝学的検査市場、技術別、2019～2032年
    • アジア太平洋：遺伝学的検査市場、疾患タイプ別、2019～2032年
    • 遺伝学的検査市場- 中国
    • 遺伝学的検査市場- インド
    • 遺伝学的検査市場- マレーシア
    • 遺伝学的検査市場- 日本
    • 遺伝学的検査市場- インドネシア
    • 遺伝学的検査市場- 韓国
  • 遺伝学的検査市場-中東およびアフリカ
    • 中東およびアフリカ：遺伝学的検査市場、技術別、2019～2032年
    • 中東およびアフリカ：遺伝学的検査市場、疾患タイプ別、2019～2032年
    • 遺伝学的検査市場- サウジアラビア
    • 遺伝学的検査市場-UAE
    • 遺伝学的検査市場- イスラエル
    • 遺伝学的検査市場- 南アフリカ
  • 遺伝学的検査市場-ラテンアメリカ
    • ラテンアメリカ：遺伝学的検査市場、技術別、2019～2032年
    • ラテンアメリカ：遺伝学的検査市場、疾患タイプ別、2019～2032年
    • 遺伝的検査市場- メキシコ
    • 遺伝学的検査市場- ブラジル
    • 遺伝学的検査市場- アルゼンチン

第8章 競合情勢

  • 拡大と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第9章 企業プロファイル

  • include AL-KO KOBER GROUP
  • Andreas Stihl AG & Company KG
  • Ariens Company
  • Briggs & Stratton
  • CHEVRON（China）Trading Co.Ltd
  • Deere & Company
  • Emak S.p.A
  • Excel Industries
  • Inc., HONDA
  • Husqvarna
  • Makita Corp
  • MTD Holdings Inc
  • Robert Bosch
  • Schiller Ground Care
  • Stanley Black & Decker
  • STIHL Group
  • Techtronic Industries
  • The Toro Company（米国）
  • Yamabiko Corp
図表

List of Tables

  • Table 1 Global Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
  • Table 2 Global Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 3 Hereditary Testing Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 4 North America: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
  • Table 5 North America: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 6 U.S.: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
  • Table 7 U.S.: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 8 Canada: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
  • Table 9 Canada: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 10 Europe: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
  • Table 11 Europe: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 12 UK: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
  • Table 13 UK: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 14 France: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
  • Table 15 France: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 16 Germany: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
  • Table 17 Germany: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 18 Italy: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
  • Table 19 Italy: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 20 Spain: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
  • Table 21 Spain: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 22 Netherlands: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
  • Table 23 Netherlands: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 24 Russia: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
  • Table 25 Russia: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 26 Asia Pacific: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
  • Table 27 Asia Pacific: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 28 China: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
  • Table 29 China: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 30 India: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
  • Table 31 India: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 32 Malaysia: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
  • Table 33 Malaysia: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 34 Japan: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
  • Table 35 Japan: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 36 Indonesia: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
  • Table 37 Indonesia: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 38 South Korea: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
  • Table 39 South Korea: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 40 Middle East & Africa: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
  • Table 41 Middle East & Africa: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 42 Saudi Arabia: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
  • Table 43 Saudi Arabia: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 44 UAE: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
  • Table 45 UAE: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 46 Israel: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
  • Table 47 Israel: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 48 South Africa: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
  • Table 49 South Africa: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 50 Latin America: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
  • Table 51 Latin America: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 52 Mexico: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
  • Table 53 Mexico: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 54 Brazil: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
  • Table 55 Brazil: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 56 Argentina: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
  • Table 57 Argentina: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)

List of Figures

  • Figure 1 Global Hereditary Testing Market, 2019-2032 (USD Billion)
  • Figure 2 Integrated Ecosystem
  • Figure 3 Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4 Market by Geography
  • Figure 5 Porter's Five Forces
  • Figure 6 Market by Technology
  • Figure 7 Global Hereditary Testing Market, by Technology, 2022 & 2032 (USD Billion)
  • Figure 8 Market by Disease Type
  • Figure 9 Global Hereditary Testing Market, by Disease Type, 2022 & 2032 (USD Billion)
  • Figure 10 Hereditary Testing Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Figure 11 Strategic Analysis - Hereditary Testing Market
目次
Product Code: PM1774

The global hereditary testing market size is expected to reach USD 13.03 billion by 2032, according to a new study by Polaris Market Research. The report "Hereditary Testing Market Share, Size, Trends, Industry Analysis Report, By Disease Type (Hereditary Cancer Testing and Hereditary Non-Cancer Testing); By Technology; By Region; Segment Forecast, 2023 - 2032" gives a detailed insight into the current market dynamics and provides analysis on future market growth.

The hereditary testing market has experienced significant growth due to various factors. The increasing prevalence of hereditary disorders, rising awareness about the importance of early disease detection, and advancements in genetic testing technologies have contributed to the expansion of this market. Hereditary testing is crucial in identifying genetic mutations and abnormalities, enabling early intervention, personalized treatments, and informed decision-making for patients and their families.

Moreover, there has been a notable focus on women's healthcare and reproductive genetic health in the hereditary testing market. Companies are developing and offering specialized tests for women's health, such as carrier screening and prenatal testing, to assess the risk of hereditary conditions during pregnancy and enable informed choices.

However, the COVID-19 pandemic has presented challenges to the hereditary testing market. Disruptions in healthcare services, including limitations on in-person consultations and laboratory operations, have impacted the market's growth. Nevertheless, the market has shown resilience with adopting telemedicine and recognizing the importance of prenatal testing in maintaining the demand for hereditary testing services. As the understanding of genetics advances and technology continues to evolve, the hereditary testing market is expected to expand further in the coming years.

Hereditary Testing Market Report Highlights

The hereditary non-cancer testing segment dominated the market in 2022 and is projected to grow significantly. Major players are strategically targeting breast cancer genetic testing for revenue generation.

The molecular testing segment emerged as the market leader in 2022 and is expected to maintain strong growth due to increased adoption and strategic initiatives by market players.

Europe is projected to hold the largest revenue market share in 2022 and maintain dominance due to major genetic testing companies, widespread use of advanced therapies, and government regulations promoting hereditary testing.

The global key market players AL-KO KOBER GROUP, Andreas Stihl AG & Company KG, Ariens Company, Briggs & Stratton, CHEVRON (China) Trading Co., Ltd., Deere & Company, Emak S.p.A., Excel Industries, Inc., HONDA, Husqvarna, Makita Corp, MTD Holdings Inc., Robert Bosch, Schiller Ground Care, Stanley Black & Decker, STIHL Group, Techtronic Industries, The Toro Company (US), and Yamabiko Corp.

Polaris Market Research has segmented the Hereditary Testing market report based on disease type, technology, and region:

Hereditary Testing, Disease Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Hereditary Cancer Testing
  • Lung Cancer
  • Breast Cancer
  • Colorectal Cancer
  • Cervical Cancer
  • Ovarian Cancer
  • Prostate Cancer
  • Stomach/Gastric Cancer
  • Melanoma
  • Sarcoma
  • Uterine Cancer
  • Pancreatic Cancer
  • Others
  • Hereditary Non-Cancer Testing
  • Genetic Tests
  • Cardiac Diseases
  • Rare Diseases
  • Other Diseases
  • Newborn Genetic Screening
  • Preimplantation Genetic Diagnosis & Screening
  • Non-invasive Prenatal Testing (NIPT) & Carrier Screening Tests

Hereditary Testing, Technology Outlook (Revenue - USD Billion, 2019 - 2032)

  • Cytogenetic
  • Biochemical
  • Molecular Testing

Hereditary Testing, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Hereditary Testing Market Insights

  • 4.1. Hereditary Testing Market - Industry Snapshot
  • 4.2. Hereditary Testing Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increase in the frequency of hereditary disorders, increased public awareness of the negative consequences, advancements in genetic analysis are the major drivers of this market
      • 4.2.1.2. Growing reproduction genetic health arena
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High cost of hereditary testing
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Hereditary Testing Industry trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Hereditary Testing Market, by Disease Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Hereditary Testing, by Disease Type, 2019-2032 (USD Billion)
  • 5.3. Hereditary Cancer Testing
    • 5.3.1. Global Hereditary Testing Market, by Hereditary Cancer Testing, by Region, 2019-2032 (USD Billion)
  • 5.4. Lung Cancer
    • 5.4.1. Global Hereditary Testing Market, by Lung Cancer, by Region, 2019-2032 (USD Billion)
  • 5.5. Breast Cancer
    • 5.5.1. Global Hereditary Testing Market, by Breast Cancer, by Region, 2019-2032 (USD Billion)
  • 5.6. Colorectal Cancer
    • 5.6.1. Global Hereditary Testing Market, by Colorectal Cancer, by Region, 2019-2032 (USD Billion)
  • 5.7. Cervical Cancer
    • 5.7.1. Global Hereditary Testing Market, by Cervical Cancer, by Region, 2019-2032 (USD Billion)
  • 5.8. Ovarian Cancer
    • 5.8.1. Global Hereditary Testing Market, by Ovarian Cancer, by Region, 2019-2032 (USD Billion)
  • 5.9. Prostate Cancer
    • 5.9.1. Global Hereditary Testing Market, by Prostate Cancer, by Region, 2019-2032 (USD Billion)
  • 5.10. Stomach/Gastric Cancer
    • 5.10.1. Global Hereditary Testing Market, by Stomach/Gastric Cancer, by Region, 2019-2032 (USD Billion)
  • 5.11. Melanoma
    • 5.11.1. Global Hereditary Testing Market, by Melanoma, by Region, 2019-2032 (USD Billion)
  • 5.12. Sarcoma
    • 5.12.1. Global Hereditary Testing Market, by Sarcoma, by Region, 2019-2032 (USD Billion)
  • 5.13. Uterine Cancer
    • 5.13.1. Global Hereditary Testing Market, by Uterine Cancer, by Region, 2019-2032 (USD Billion)
  • 5.14. Pancreatic Cancer
    • 5.14.1. Global Hereditary Testing Market, by Pancreatic Cancer, by Region, 2019-2032 (USD Billion)
  • 5.15. Others
    • 5.15.1. Global Hereditary Testing Market, by Others, by Region, 2019-2032 (USD Billion)
  • 5.16. Hereditary Non-Cancer Testing
    • 5.16.1. Global Hereditary Testing Market, by Hereditary Non-Cancer Testing, by Region, 2019-2032 (USD Billion)
  • 5.17. Genetic Tests
    • 5.17.1. Global Hereditary Testing Market, by Genetic Tests Testing, by Region, 2019-2032 (USD Billion)
  • 5.18. Cardiac Diseases
    • 5.18.1. Global Hereditary Testing Market, by Cardiac Diseases Testing, by Region, 2019-2032 (USD Billion)
  • 5.19. Rare Diseases
    • 5.19.1. Global Hereditary Testing Market, by Rare Diseases Testing, by Region, 2019-2032 (USD Billion)
  • 5.20. Other Diseases
    • 5.20.1. Global Hereditary Testing Market, by Other Diseases Testing, by Region, 2019-2032 (USD Billion)
  • 5.21. Newborn Genetic Screening
    • 5.21.1. Global Hereditary Testing Market, by Newborn Genetic Screening Testing, by Region, 2019-2032 (USD Billion)
  • 5.22. Preimplantation Genetic Diagnosis & Screening
    • 5.22.1. Global Hereditary Testing Market, by Preimplantation Genetic Diagnosis & Screening Testing, by Region, 2019-2032 (USD Billion)
  • 5.23. Non-invasive Prenatal Testing (NIPT) & Carrier Screening Tests
    • 5.23.1. Global Hereditary Testing Market, by Non-invasive Prenatal Testing (NIPT) & Carrier Screening Tests Testing, by Region, 2019-2032 (USD Billion)

6. Global Hereditary Testing Market, by Technology

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
  • 6.3. Cytogenetic
    • 6.3.1. Global Hereditary Testing Market, by Cytogenetic, by Region, 2019-2032 (USD Billion)
  • 6.4. Biochemical
    • 6.4.1. Global Hereditary Testing Market, by Biochemical, by Region, 2019-2032 (USD Billion)
  • 6.5. Molecular Testing
    • 6.5.1. Global Hereditary Testing Market, by Molecular Testing, by Region, 2019-2032 (USD Billion)

7. Global Hereditary Testing Market, by Geography

  • 7.1. Key findings
  • 7.2. Introduction
    • 7.2.1. Hereditary Testing Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 7.3. Hereditary Testing Market - North America
    • 7.3.1. North America: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
    • 7.3.2. North America: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
    • 7.3.3. Hereditary Testing Market - U.S.
      • 7.3.3.1. U.S.: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
      • 7.3.3.2. U.S.: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
    • 7.3.4. Hereditary Testing Market - Canada
      • 7.3.4.1. Canada: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
      • 7.3.4.2. Canada: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
  • 7.4. Hereditary Testing Market - Europe
    • 7.4.1. Europe: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
    • 7.4.2. Europe: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
    • 7.4.3. Hereditary Testing Market - UK
      • 7.4.3.1. UK: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
      • 7.4.3.2. UK: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
    • 7.4.4. Hereditary Testing Market - France
      • 7.4.4.1. France: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
      • 7.4.4.2. France: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
    • 7.4.5. Hereditary Testing Market - Germany
      • 7.4.5.1. Germany: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
      • 7.4.5.2. Germany: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
    • 7.4.6. Hereditary Testing Market - Italy
      • 7.4.6.1. Italy: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
      • 7.4.6.2. Italy: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
    • 7.4.7. Hereditary Testing Market - Spain
      • 7.4.7.1. Spain: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
      • 7.4.7.2. Spain: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
    • 7.4.8. Hereditary Testing Market - Netherlands
      • 7.4.8.1. Netherlands: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
      • 7.4.8.2. Netherlands: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
    • 7.4.9. Hereditary Testing Market - Russia
      • 7.4.9.1. Russia: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
      • 7.4.9.2. Russia: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
  • 7.5. Hereditary Testing Market - Asia Pacific
    • 7.5.1. Asia Pacific: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
    • 7.5.2. Asia Pacific: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
    • 7.5.3. Hereditary Testing Market - China
      • 7.5.3.1. China: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
      • 7.5.3.2. China: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
    • 7.5.4. Hereditary Testing Market - India
      • 7.5.4.1. India: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
      • 7.5.4.2. India: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
    • 7.5.5. Hereditary Testing Market - Malaysia
      • 7.5.5.1. Malaysia: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
      • 7.5.5.2. Malaysia: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
    • 7.5.6. Hereditary Testing Market - Japan
      • 7.5.6.1. Japan: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
      • 7.5.6.2. Japan: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
    • 7.5.7. Hereditary Testing Market - Indonesia
      • 7.5.7.1. Indonesia: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
      • 7.5.7.2. Indonesia: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
    • 7.5.8. Hereditary Testing Market - South Korea
      • 7.5.8.1. South Korea: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
      • 7.5.8.2. South Korea: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
  • 7.6. Hereditary Testing Market - Middle East & Africa
    • 7.6.1. Middle East & Africa: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
    • 7.6.2. Middle East & Africa: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
    • 7.6.3. Hereditary Testing Market - Saudi Arabia
      • 7.6.3.1. Saudi Arabia: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
      • 7.6.3.2. Saudi Arabia: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
    • 7.6.4. Hereditary Testing Market - UAE
      • 7.6.4.1. UAE: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
      • 7.6.4.2. UAE: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
    • 7.6.5. Hereditary Testing Market - Israel
      • 7.6.5.1. Israel: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
      • 7.6.5.2. Israel: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
    • 7.6.6. Hereditary Testing Market - South Africa
      • 7.6.6.1. South Africa: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
      • 7.6.6.2. South Africa: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
  • 7.7. Hereditary Testing Market - Latin America
    • 7.7.1. Latin America: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
    • 7.7.2. Latin America: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
    • 7.7.3. Hereditary Testing Market - Mexico
      • 7.7.3.1. Mexico: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
      • 7.7.3.2. Mexico: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
    • 7.7.4. Hereditary Testing Market - Brazil
      • 7.7.4.1. Brazil: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
      • 7.7.4.2. Brazil: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
    • 7.7.5. Hereditary Testing Market - Argentina
      • 7.7.5.1. Argentina: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
      • 7.7.5.2. Argentina: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)

8. Competitive Landscape

  • 8.1. Expansion and Acquisition Analysis
    • 8.1.1. Expansion
    • 8.1.2. Acquisitions
  • 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

  • 9.1. include AL-KO KOBER GROUP
    • 9.1.1. Company Overview
    • 9.1.2. Financial Performance
    • 9.1.3. Product Benchmarking
    • 9.1.4. Recent Development
  • 9.2. Andreas Stihl AG & Company KG
    • 9.2.1. Company Overview
    • 9.2.2. Financial Performance
    • 9.2.3. Product Benchmarking
    • 9.2.4. Recent Development
  • 9.3. Ariens Company
    • 9.3.1. Company Overview
    • 9.3.2. Financial Performance
    • 9.3.3. Product Benchmarking
    • 9.3.4. Recent Development
  • 9.4. Briggs & Stratton
    • 9.4.1. Company Overview
    • 9.4.2. Financial Performance
    • 9.4.3. Product Benchmarking
    • 9.4.4. Recent Development
  • 9.5. CHEVRON (China) Trading Co.Ltd
    • 9.5.1. Company Overview
    • 9.5.2. Financial Performance
    • 9.5.3. Product Benchmarking
    • 9.5.4. Recent Development
  • 9.6. Deere & Company
    • 9.6.1. Company Overview
    • 9.6.2. Financial Performance
    • 9.6.3. Product Benchmarking
    • 9.6.4. Recent Development
  • 9.7. Emak S.p.A
    • 9.7.1. Company Overview
    • 9.7.2. Financial Performance
    • 9.7.3. Product Benchmarking
    • 9.7.4. Recent Development
  • 9.8. Excel Industries
    • 9.8.1. Company Overview
    • 9.8.2. Financial Performance
    • 9.8.3. Product Benchmarking
    • 9.8.4. Recent Development
  • 9.9. Inc., HONDA
    • 9.9.1. Company Overview
    • 9.9.2. Financial Performance
    • 9.9.3. Product Benchmarking
    • 9.9.4. Recent Development
  • 9.10. Husqvarna
    • 9.10.1. Company Overview
    • 9.10.2. Financial Performance
    • 9.10.3. Product Benchmarking
    • 9.10.4. Recent Development
  • 9.11. Makita Corp
    • 9.11.1. Company Overview
    • 9.11.2. Financial Performance
    • 9.11.3. Product Benchmarking
    • 9.11.4. Recent Development
  • 9.12. MTD Holdings Inc
    • 9.12.1. Company Overview
    • 9.12.2. Financial Performance
    • 9.12.3. Product Benchmarking
    • 9.12.4. Recent Development
  • 9.13. Robert Bosch
    • 9.13.1. Company Overview
    • 9.13.2. Financial Performance
    • 9.13.3. Product Benchmarking
    • 9.13.4. Recent Development
  • 9.14. Schiller Ground Care
    • 9.14.1. Company Overview
    • 9.14.2. Financial Performance
    • 9.14.3. Product Benchmarking
    • 9.14.4. Recent Development
  • 9.15. Stanley Black & Decker
    • 9.15.1. Company Overview
    • 9.15.2. Financial Performance
    • 9.15.3. Product Benchmarking
    • 9.15.4. Recent Development
  • 9.16. STIHL Group
    • 9.16.1. Company Overview
    • 9.16.2. Financial Performance
    • 9.16.3. Product Benchmarking
    • 9.16.4. Recent Development
  • 9.17. Techtronic Industries
    • 9.17.1. Company Overview
    • 9.17.2. Financial Performance
    • 9.17.3. Product Benchmarking
    • 9.17.4. Recent Development
  • 9.18. The Toro Company (US)
    • 9.18.1. Company Overview
    • 9.18.2. Financial Performance
    • 9.18.3. Product Benchmarking
    • 9.18.4. Recent Development
  • 9.19. Yamabiko Corp
    • 9.19.1. Company Overview
    • 9.19.2. Financial Performance
    • 9.19.3. Product Benchmarking
    • 9.19.4. Recent Development